Alnylam Pharmaceuticals Inc
XETRA:DUL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Alnylam Pharmaceuticals Inc
XETRA:DUL
|
US |
|
Wendys Co
NASDAQ:WEN
|
US |
|
Boise Cascade Co
NYSE:BCC
|
US |
|
S
|
Sun Hung Kai Properties Ltd
XMUN:SHG
|
HK |
|
Stem Inc
NYSE:STEM
|
US |
|
SM Energy Co
NYSE:SM
|
US |
|
3
|
3D Systems Corp
SWB:SYV
|
US |
|
S
|
SandRidge Energy Inc
SWB:SA2D
|
US |
|
Daikin Industries Ltd
TSE:6367
|
JP |
|
I
|
Imperial Oil Ltd
AMEX:IMO
|
CA |
|
E
|
Eni SpA
DUS:ENI
|
IT |
|
E
|
Exelon Corp
BMV:EXC
|
US |
|
C
|
Coloplast A/S
F:CBHD
|
DK |
|
S
|
Shell PLC
AEX:SHELL
|
UK |
|
United Microelectronics Corp
TWSE:2303
|
TW |
|
Airtel Africa PLC
LSE:AAF
|
UK |
|
Primerica Inc
NYSE:PRI
|
US |
|
K
|
KDDI Corp
SWB:DIP
|
JP |
|
Dentsu Group Inc
TSE:4324
|
JP |
|
L
|
Liberty Global PLC
XBER:1LGC
|
UK |
|
A
|
Andean Precious Metals Corp
OTC:ANPMF
|
CA |
|
Fomento de Construcciones y Contratas SA
MAD:FCC
|
ES |
|
Titan Company Ltd
BSE:500114
|
IN |
|
Home Depot Inc
NYSE:HD
|
US |
Bankruptcy Probability
Alnylam Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Alnylam Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
38.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
447.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
193.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
158.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
124.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
66.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Alnylam Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Alnylam Pharmaceuticals Inc has total debt of 2.5B USD. This includes both short-term (0 USD) and long-term (2.5B USD) debt.
You can find a full breakdown on its Balance Sheet.
